Novartis’ LEE011 ‘priority’ tag hastens showdown with Pfizer’s Ibrance, but do safety concerns portend a blowout?

Novartis' LEE011 'priority' tag hastens showdown with Pfizer's Ibrance, but do safety concerns portend a blowout? chelfand Tue, 11/01/2016 - 03:18…
Read the full story: Feed